The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 4 October 2012 up to and including 10 October 2012 the Company bought 1020 own shares representing 0.00077% of the share capital of the Company, to the total value of BGN 2432.6 on the Bulgarian Stock Exchange. The average price per share was BGN 2.38.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

Sopharma AD notifies that for May 2015 the Company recorded an increase of sales revenues of 3% compared to the same month of 2014, including 14% increase of domestic sales and 2% decrease of export sales.

For the five months of this year, revenues from sales decreased by 12% compared to the same period of 2014, including 16% increase of domestic sales and a 22% decrease of export sales.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that in order to achieve synergies in the Sopharma Group, optimization of the management of products in the domestic market and higher efficiency of resources, the team responsible for the products produced by Sopharma AD and intended for the free market (OTC products) in being transferred to Sopharma Trading AD. The management of both companies believes that this is a logical step in improving the performance and quality of the work of the Group.

Sopharma AD (the “Company”) hereby notifies all shareholders of the Company, that the Annual General Meeting, convened by the Board of Directors for 19 June 2015 at 11:00 will take place at Sopharma Business Towers, Building B, floor 3, 5 Lachezar Stanchev Str.. The registration begins at 9:30.

All shareholders of the company are invited to participate at the General Meeting in person or by proxy.

SOPHARMA AD hereby informs that from 23 July 2015 up to and including 28 July 2015 the Company bought 5000 own shares representing 0.0037% of the share capital of the Company, at a total value of 13 800.00 BGN on the Bulgarian Stock Exchange, the average price per share was 2.76 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 174 832, representing 3.84% of the share capital of the Company.

Sopharma AD (the “Company”) announces that on 28 July 2015 the Company bought 937 000 ordinary registered shares with voting rights of the capital of United Holding Doverie AD. After this transaction, the share of Sopharma AD in the capital of United Holding Doverie AD increased to 14.898%.